治疗组内服银杏叶胶囊，对照组服用安慰剂。
The treatment group takes orally the gingko leaf capsule, the control group takes the placebo.
银杏叶胶囊是一种新品种、新剂型的中成药，副作用少。
Ginkgo capsule, one of the Chinese patent drugs, is a new product in new form with few side effects.
经方法学验证试验得出的检查方法可用于驴胶补血颗粒、银杏叶胶囊的微生物限度检查。
The validation results showed that the method could be used for microbial limit test for Liujiaobuxue Granules and Yinxingye Capsules.
结论：银杏叶胶囊可以改善原发性闭角青光眼手术后眼压控制患者的视野，表明其具有一定的视神经保护作用。
Objective:To evaluate the neuroprotection effect of Ginkgo leaf capsules on primary angle closure glaucoma patients after surgical therapy whose intraocular pressure were controlled.
为使银杏叶提取物能在食品领域得到充分有价值的应用，探索采用微胶囊技术来解决银杏类黄酮难溶于水及强烈苦味的问题。
Microencapsulation of extracts from gingko leaves can be used as a function food additive to solve some problems such as undissolved property in water and the bitterness of gingko flavonoids.
目的：观察复方银杏叶萃取物胶囊（静可福）用于痔手术后减轻水肿、疼痛、渗血的疗效。
Objective:To observe the effect of Compound Ginkgo Biloba Extract Capsule(Ginkor fort)on reduction of bleeding, pain and edema after operation of hemorrhoids.
本文综述银杏叶制剂的研究进展，其中有片剂、胶囊剂、冲剂、口服液、气雾剂及注射液等，并有多种银杏叶的复方制剂。
The studies of preparations of ginkgo leaves, including tablets, capsules, granules, oral solution, aerosol, injection as well as its compound preparations are summarized.
本发明公开了一种银杏灵芝孢子胶囊，它由20％纯银杏叶提取物和80％灵芝真菌丝组成。
The invention discloses a ginkgo ganoderma lucidum spore capsule, which consists of 20 percent of pure ginkgo leave extract and 80 percent of ganoderma lucidum fungal mycelia.
本发明公开了一种银杏灵芝孢子胶囊，它由20％纯银杏叶提取物和80％灵芝真菌丝组成。
The invention discloses a ginkgo ganoderma lucidum spore capsule, which consists of 20 percent of pure ginkgo leave extract and 80 percent of ganoderma lucidum fungal mycelia.
应用推荐